⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24599370 | 1.00 | — | — | |
| SCHEMBL5354 | 0.75 | — | — | |
| Hydrochloric Acid SCHEMBL2671055 | 0.72 | — | — | |
| SCHEMBL15695396 | 0.72 | — | — | |
| SCHEMBL7608901 | 0.72 | — | — | |
| Fluoride SCHEMBL11339901 | 0.72 | — | — | |
| SCHEMBL7586263 | 0.72 | — | — | |
| SCHEMBL25485923 | 0.72 | — | — | |
| SCHEMBL21097522 | 0.72 | — | — | |
| SCHEMBL11695182 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11542262-B2 | Phosphatidylinositol 3-kinase inhibitors | NANJING ZHENGXIANG PHARMACEUTICALS CO., LTD. (CN) | 2023-01-03 | — | — | US | disclosed |
| US-20220220113-A1 | PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS | NANJING ZHENGXIANG PHARMACEUTICALS CO., LTD. (CN) | 2022-07-14 | — | — | US | disclosed |
| US-20220213096-A1 | PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS | NANJING ZHENGXIANG PHARMACEUTICALS CO LTD (CN) | 2022-07-07 | — | — | US | disclosed |